Anebulo Pharmaceuticals Reports Q2 Financial Results, Plans To Develop Therapy For Acute Cannabinoid Intoxication
Anebulo Pharmaceuticals, Inc. (NASDAQ: ANEB) announced financial results for the three months ended December 31, 2021 and recent updates.